Publicación:
Epidemiological and viral features of a cohort of SARS‑CoV‑2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean

dc.contributor.authorMattar Velilla, Ameth Salim
dc.contributor.authorMartínez Bravo, Caty Milena
dc.contributor.authorRivero, Ricardo
dc.contributor.authorContreras, Héctor
dc.contributor.authorFaccini Martínez, Álvaro Adolfo
dc.contributor.authorGuzmán Terán, Camilo Antonio
dc.contributor.authorGaleano Anaya, Ketty Esther
dc.contributor.authorAlvis Guzmán, Nelson
dc.contributor.authorContreras Cogollo, Veronica
dc.contributor.authorArrieta Bernate, Germán Javier
dc.contributor.authorGonzález Tous, Marco
dc.contributor.authorMiranda Regino, Jorge Luis
dc.contributor.authorOspina, Martha
dc.contributor.authorCamargo Assis, Francisco
dc.contributor.authorMercado Reyes, Marcela
dc.contributor.authorGaray Montalvo, Evelin
dc.contributor.authorGarcía Pérez, Alejandra
dc.contributor.authorLópez Mejía, Yesica Paola
dc.contributor.authorTique Salleg, Vaneza Paulin
dc.contributor.corporatenameCorporación Universitaria del caribe - CECAR
dc.contributor.researchgroupSalud Pública y Auditoría en Salud
dc.date.accessioned2025-08-28T16:54:37Z
dc.date.issued2020
dc.description.abstractBackground: Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is an emerging viral pandemic disease. In the last 6 months, SARS-CoV-2 has caused millions of reported cases and hundreds of thousands of deaths. As other world regions, South America has not contained the pandemic’s advance since it lacks the hospital and economic capacities. Public health implications of transmission, while the asymptomatic/presymptomatic infection is a critical concern at the current pandemic. Objective: Describe the socio-demographic, clinical, and viral features of a cohort of SARS-CoV-2 infected individuals from the Colombian Caribbean. Methods: Six hundred eighty-six clinical samples of suspected SARS-CoV-2 infection cases and contacts individuals from several hospital centers in the department of Córdoba, Colombia, were received at our laboratory between April 9th and May 16th, 2020. RNA was extracted using lysis buffers and spin columns. The samples were tested for SARSCoV-2 by reverse transcription real-time polymerase chain reaction (RT-qPCR) using commercially available multiplex real-time PCR assay for simultaneous detection of 3 target genes of SARS-CoV-2 (Allplex™, 2019-nCoV assay, Korea). Viral copies quantification was done using a standard curve constructed from seriated dilutions of a SARS-CoV-2 posi‑ tive control. Statics descriptive methods were used. Results: Thirty-five nasopharyngeal samples were positive for SARS-CoV-2 infection; the average age was 43 (range, 1–95 years). Seventeen of 35 (49%) of the patients showed symptoms. Most of them had a cough, fever, and odynophagia; three of the patients reported having arthralgia. Only two patients required hospitalization. None of the patients had known co-morbidities. RT-qPCR results show that two of the symptomatic patients had significantly higher RNA copies than the rest. Eighteen of 35 (51%) individuals were asymptomatic, and the average age was 30 (range, 6–61 years). Four asymptomatic individuals showed a higher copy than some symptomatic patients; nonethe‑ less, the average of RNA copies 8.26×1010 was lower than the symptomatic. Conclusions: This study shows that asymptomatic patients may develop infections with a high number of RNA copies. Since a considerable percentage of infections may be asymptomatic/presymptomatic, enhanced testing approaches may be needed to detect these persons. Due the occurrence of a large proportion of infections being a result from transmission originated in asymptomatic/presymptomatic individuals, public health interventions in Colombia should be based on two steps: a massive molecular screening, and viral load quantification. Finally, a remarkable issue in our study is the average age of symptomatic and asymptomatic groups (43 and 30 respectively) which may be important because of the economic impact that has been caused by the coronavirus pandemic and may be probably the cause of the reduced lethality observed in the country and the department at the time of this study.
dc.description.researchareaAuditoría en Salud
dc.description.researchareaSalud Pública
dc.format.extent6 páginas
dc.format.mimetypeapplication/pdf
dc.identifier.eissn1476-0711
dc.identifier.urihttps://repositorio.cecar.edu.co/handle/cecar/10793
dc.publisher.placeColombia
dc.relation.citationendpage6
dc.relation.citationstartpage1
dc.relation.citationvolumeVolumen 19
dc.relation.ispartofjournalAnnals of Clinical Microbiology and Antimicrobials
dc.relation.referencesWorldometers. 2020. https://www.worldometers.info/coronaviru s/#countries. Accessed 18 Oct 2020.
dc.relation.referencesInstituto Nacional de Salud de Colombia. https://www.ins.gov.co/Notic ias/Paginas/Coronavirus.aspx. Accessed 18 Oct 2020.
dc.relation.referencesOPS. Actualización situación COVID-19 Colombia, 14 de octubre. https ://www.paho.org/es/documentos/reporte-situacion-covid-19-colom bia-no-159-14-octubre-2020.
dc.relation.referencesDabiao Ch, Wenxiong X, Ziying L, Zhanlian H, Jing L, Zhiliang G, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis. 2020;93:297–9.
dc.relation.referencesFurukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while pre symptomatic or asymptomatic. Emerg Infect Dis. 2020. https://doi.org/10.3201/eid26 07.201595.
dc.relation.referencesMichael RT, Mina MJ. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa619.
dc.relation.referencesSethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020;323(22):2249–51. https://doi.org/10.1001/ jama.2020.8259.
dc.relation.referencesLiu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656–7. https ://doi.org/10.1016/S1473-3099(20)30232-2.
dc.relation.referencesEun S, Seong H, Yu Y, Un S, Kim S. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. Int J Infect Dis. 2020;95:441–3.
dc.relation.referencesSun J, Xiao J, Sun R, Tang X, Liang C, Lin H, et al. Prolonged persistence of SARS-CoV-2 RNA in body fluids. Emerg Infect Dis. 2020. https://doi. org/10.3201/eid2608.201097.
dc.relation.referencesWajnberg A, Mansour M, Leven E, Bouvier NM, Patel G, Firpo A, et al. Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region. medRxiv. 2020. https://doi.org/10.1101/2020.04.30.20085613.
dc.rightsDerechos reservados - Corporación Universitaria de Caribe - CECAR
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.licenseAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourcehttps://doi.org/10.1186/s12941-020-00397-5
dc.subject.proposalAsymptomatic infections
dc.subject.proposalCOVID-19
dc.subject.proposalCoronavirus infections
dc.subject.proposalPre symptomatic disease
dc.subject.proposalEnvironment and public health
dc.subject.proposalCommunicable disease control
dc.titleEpidemiological and viral features of a cohort of SARS‑CoV‑2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbeaneng
dc.typeArtículo de revista
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.contentText
dc.type.driverinfo:eu-repo/semantics/article
dc.type.redcolhttp://purl.org/redcol/resource_type/ART
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
s12941-020-00397-5.pdf
Tamaño:
1.26 MB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
14.49 KB
Formato:
Item-specific license agreed upon to submission
Descripción: